Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2736 USD | +5.23% |
|
+8.57% | -36.39% |
05-23 | Theriva Biologics Gets Fast Track Designation for Pancreatic Cancer Treatment | MT |
05-23 | Theriva Biologics, Inc Announces U.S. Food and Drug Administration Granted Fast Track Designation | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.39% | 4.73M | |
+20.63% | 127B | |
+24.83% | 27.67B | |
-20.17% | 20.33B | |
-16.91% | 16.79B | |
-18.07% | 15.63B | |
-47.70% | 14.65B | |
+11.92% | 14.84B | |
+58.32% | 14.43B | |
+149.98% | 12.49B |
- Stock Market
- Equities
- TOVX Stock
- News Theriva Biologics, Inc.
- Transcript : Theriva Biologics, Inc. Presents at B. Riley Securities' 3rd Annual Oncology Conference, Jan-19-2023 01